Document is current
Any future updates will be listed below
-
Authors
Loh, Kah Poh
Sanapala, Chandrika
Jensen-Battaglia, Marielle
Rana, Anish
Sohn, Michael B.
Watson, Erin
Gilmore, Nikesha
Klepin, Heidi D.
Mendler, Jason H.
Liesveld, Jane
Huselton, Eric
LoCastro, Marissa
Susiarjo, Martha
Netherby-Winslow, Colleen
Williams, AnnaLynn M.
Mustian, Karen
Vertino, Paula
Janelsins, Michelle C.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04981821 at ClinicalTrials.govDocuments that mention this clinical trial
Exercise and epigenetic ages in older adults with myeloid malignancies
https://doi.org/10.1186/s40001-023-01145-z
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R00CA237744, UG1 CA189961)
- License Information
-
More Information
Article History
Received: 27 December 2022
Accepted: 19 May 2023
First Online: 30 May 2023
Declarations
:
: The University of Rochester Research Subjects Review Board approved this study. All participants provided informed consent.
: No individual-level data are included in the manuscript.
: Dr. Loh has served as a consultant to Pfizer and Seattle Genetics and has received honoraria from Pfizer. All other authors have no relevant competing interests to report<b>.</b>
